Opendata, web and dolomites

PrevictDrugs SIGNED

Smartphone Measured Eye-Based Digital Biomarkers for Drug Use Detection

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 PrevictDrugs project word cloud

Explore the words cloud of the PrevictDrugs project. It provides you a very rough idea of what is the project "PrevictDrugs" about.

drugs    extreme    record    acceptance    treatments    innovative    disorders    illicit    disruptive    pharmacodynamically    outcomes    daily    continuous    app    pupillometry    transform    asked    suffering    patient    monitoring    eyes    caregivers    personal    tools    thing    medical    global    gambling    prepare    commercialisation    million    abuse    previct    device    mood    care    privacy    smartphone    worldwide    addictive    efficient    combine    time    self    constitute    personalised    ai    prioritisation    reactions    place    risks    unbound    sophisticated    cravings    efficiency    voluntary    designed    screenings    nearly    fast    validating    routes    therapy    ab    clinical    interventions    module    kontigo    add    correct    instead    video    biomarkers    hazard    addiction    suffer    instantly    drive    drug    ing    ehealth    relapse    convenience    platform    digitalisation    complete    cameras    market    gaining    distance    pupil    healthcare    settings    sobriety    yield    solution    proactive    instant    portal    alcohol    reactive    internet    iot    eye    cloud    communication    patients   

Project "PrevictDrugs" data sheet

The following table provides information about the project.

Coordinator
KONTIGO CARE AB 

Organization address
address: PAVEL SNICKARES GRAND 12
city: UPPSALA
postcode: 753 20
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Sweden [SE]
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-09-01   to  2020-02-29

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    KONTIGO CARE AB SE (UPPSALA) coordinator 50˙000.00

Map

 Project objective

Drug addiction is a global problem; nearly 30 million illicit drug users worldwide suffer from problematic drug use. Kontigo Care AB is developing an innovative medical device – Previct Drugs - a robust, app-based, eHealth-platform for place unbound, continuous, voluntary, self-monitoring of drug use. It will constitute an add-on to Kontigo Care’s current eHealth offer developed for management of other addictive disorders (alcohol abuse and hazard gambling). Using smartphone cameras, patients suffering from drug addiction, will be identified, and asked to record a 10 s long video of their eyes. Analysis of eye biomarkers associated with pharmacodynamically induced pupil reactions (pupillometry) will yield instant results on drug use/sobriety. Our unique, disruptive Internet of Thing (IoT)-based approach is designed to combine continuous monitoring of drug use and daily mood/cravings, with communication tools aimed at improving the impact of distance care. Real-time results become instantly available to caregivers through our cloud-based Care Portal, allowing fast interventions and correct patient prioritisation. This eHealth solution will drive healthcare digitalisation resulting in extreme cost-efficiency of out-patient treatments as well as convenience and complete privacy during drug screenings. A sophisticated AI-system will assess personal risks of relapse and transform addiction management to become proactive instead of reactive. This approach has the potential to enhance personalised therapy outcomes by ensuring that help can be provided fast to the patients who need it the most. The project objective is to prepare for commercialisation of the Previct Drugs module by determining the most efficient routes for gaining clinical and market acceptance by validating the product in clinical settings.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PREVICTDRUGS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PREVICTDRUGS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

HUD (2018)

COMMERCIALIZING THE FIRST HEAD-UP-DISPLAY FOR OFF-HIGHWAY VEHICLES

Read More  

DeltaQon (2019)

IOT and cloud computing for online medical analysis service platform

Read More  

Dyme (2019)

Dyme gives its users complete control over their financial situation. The Dyme application provides insight into users’ spending and subscriptions, and lets users cancel, negotiate, or switch any cont

Read More